A new isoform of interleukin-32 suppresses IL-8 mRNA expression in the intestinal epithelial cell line HT-29

Molecular Medicine Reports

Volumn 4, Issue 3, 2011, Pages 483-487

  Imaeda, Hirotsugu ^a   Andoh, Akira ^a   Aomatsu, Tomoki ^a   Osaki, Rie ^a   Bamba, Shigeki ^a   Inatomi, Osamu ^a   Shimizu, Tomoharu ^a   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

HT 29; Inflammatory bowel disease; NOD2; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 32; INTERLEUKIN 32 ALPHA; INTERLEUKIN 32 BETA; INTERLEUKIN 32 DELTA; INTERLEUKIN 32 EPSILON; INTERLEUKIN 32 GAMMA; INTERLEUKIN 8; ISOPROTEIN; MESSENGER RNA; NUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; EXON; EXPRESSION VECTOR; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM CELL; MESSENGER RNA SYNTHESIS; MYOFIBROBLAST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; INTERLEUKINS; INTESTINES; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RNA, MESSENGER; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953782591     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.442     Document Type: Article

References (32)

1. Kim SH, Han SY, Azam T, Yoon DY and Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22: 131-142, 2005.
2. Netea MG, Azam T, Ferwerda G, et al: No. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102: 16309-16314, 2005.
3. Dinarello CA and Kim SH: IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65 (Suppl 3): iii61-iii64, 2006.
4. Chen Q, Carroll HP and Gadina M: The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 74: 207-228, 2006.
5. Goda C, Kanaji T, Kanaji S, et al: Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 18: 233-240, 2006.
6. Kumar S, Hanning CR, Brigham-Burke MR, et al: Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18: 61-71, 2002.
7. Pufe T, Petersen W, Tillmann B and Mentlein R: The splice variants VEGF121 and VEGF 189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 44: 1082-1088, 2001.
8. Choi JD, Bae SY, Hong JW, et al: Identification of the most active interleukin-32 isoform. Immunology 126: 535-542, 2009.
9. Mayer L: Evolving paradigms in the pathogenesis of IBD. J Gastroenterol 45: 9-16, 2010.
10. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
11. Hibi T and Ogata H: Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 41: 10-16, 2006.
12. Peyrin-Biroulet L, Vignal C, Dessein R, Simonet M, Desreumaux P and Chamaillard M: NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol 14: 432-438, 2006.
13. Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603, 2001.
14. Hugot JP: CARD15/NOD2 mutations in Crohn's disease. Ann NY Acad Sci 1072: 9-18, 2006.
15. Netea MG, Ferwerda G, De Jong DJ, et al: Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 174: 6518-6523, 2005.
16. Netea MG, Kullberg BJ, De Jong DJ, et al: NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 34: 2052-2059, 2004.
17. Maeda S, Hsu LC, Liu H, et al: Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307: 734-738, 2005.
18. Shioya M, Nishida A, Yagi Y, et al: Epithelial overexpression of interleukin-32 alpha in inflammatory bowel disease. Clin Exp Immunol 149: 480-486, 2007.
19. Kobori A, Yagi Y, Imaeda H, et al: Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 45: 999-1007, 2010.
20. Hasegawa H, Thomas HJ, Schooley K and Born TL: Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. Cytokine 53: 74-83, 2010.
21. Mahida YR, Beltinger J, Makh S, et al: Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol 273: G1341-G1348, 1997.
22. Okuno T, Andoh A, Bamba S, et al: Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 37: 317-324, 2002.
23. Zweibaum A, Pinto M, Chevalier G, et al: Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 122: 21-29, 1985.
24. Andoh A, Takaya H, Saotome T, et al: Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 119: 211-219, 2000.
25. Dahl CA, Schall R P, He HL and Cairns JS: Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 148: 597-603, 1992.
26. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 298: 82-86, 1989.
27. Best WR, Becktel JM and Singleton JW: Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 77: 843-846, 1979.
28. Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A and Fujiyama Y: Phosphatidylinositol 3-kinase Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 294: G831-G838, 2008.
29. Nishida A, Andoh A, Inatomi O and Fujiyama Y: Interleukin-32 expression in the pancreas. J Biol Chem 284: 17868-17876, 2009.
30. Kobayashi H and Lin PC: Molecular characterization of IL-32 in human endothelial cells. Cytokine 46: 351-358, 2009.
31. Tagaya Y, Kurys G, Thies TA, et al: Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci USA 94: 14444-14449, 1997.
32. Rosenstiel P, Fantini M, Brautigam K, et al: TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124: 1001-1009, 2003.